AstraZeneca expands Coppell manufacturing site, adding about 30 skilled jobs

AstraZeneca expands Coppell manufacturing site, adding about 30 skilled jobs

The Coppell site is the sole manufacturer of the drug Lokelma.

AstraZeneca Expands Texas Manufacturing Facility to Double Production of Hyperkalemia Drug

The $445 million expansion of AstraZeneca’s Coppelsite will boost global production capacity for Lokelma, enhance local job growth, and strengthen the company’s US manufacturing footprint amid industry-wide onshoring trends.

AstraZeneca doubles Lokelma output with $445m Texas plant expansion - Pharmaceutical Technology

The investment is part of AstraZeneca’s wider $50bn outlay to bolster manufacturing in the US.

AstraZeneca opens $445M expansion of Lokelma factory; Avidity Bio delays BLA for Duchenne drug

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. AstraZeneca has opened its expanded Coppell, TX, facility which makes its hyperkalemia ...